THE RESCUE DRUG COMPANY

USPTO USPTO 2012 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke THE RESCUE DRUG COMPANY wurde als Wortmarke am 14.02.2012 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Wortmarke
Aktenzeichen 85542026
Anmeldedatum 14. Februar 2012
Veröffentlichungsdatum 05. Februar 2013

Markeninhaber

2711 Centerville Road
19808 Wilmington
US

Markenvertreter

Waren und Dienstleistungen

5 Pharmaceutical preparations for new drug or the re-formation of existing drugs for use in the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as a neuroprotectant, to treat metabolic disorders, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders; Pharmaceutical preparations for new drug or the re-formation of existing drugs for use in chemotherapy, dermatology and urology
42 Development of pharmaceutical preparations and medicines for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology; Pharmaceutical drug development services for drugs for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology; Pharmaceutical research and development of drugs for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1385542026